In other studies, utilization the histone deacetylase (HDAC) inhibitor and valproic acid (VPA) enhanced EHV-1 L11ΔgIΔgE infection and caused limited glioma progression, thus improving the therapeutic potential of this virus. This evidence concerns the gene HDAC9 and glioma.